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In C6 rat brain glioma, we have investigated the relation between hypoxia and the presence of lipid droplets in the cytoplasm of
viable cells adjacent to necrosis. For this purpose, rats were stereotaxically implanted with C6 cells. Experiments were carried out by
the end of the tumour development. A multifluorescence staining protocol combined with digital image analysis was used to
quantitatively study the spatial distribution of hypoxic cells (pimonidazole), blood perfusion (Hoechst 33342), total vascular bed
(collagen type IV) and lipid droplets (Red Oil) in single frozen sections. All tumours (n¼6) showed necrosis, pimonidazole binding
and lipid droplets. Pimonidazole binding occurred at a mean distance of 114mm from perfused vessels mainly around necrosis. Lipid
droplets were principally located in the necrotic tissue. Some smaller droplets were also observed in part of the pimonidazole-binding
cells surrounding necrosis. Hence, lipid droplets appeared only in hypoxic cells adjacent to necrosis, at an approximate distance of
181mm from perfused vessels. In conclusion, our results show that severe hypoxic cells accumulated small lipid droplets. However, a
100% colocalisation of hypoxia and lipid droplets does not exist. Thus, lipid droplets cannot be considered as a surrogate marker of
hypoxia, but rather of severe, prenecrotic hypoxia.
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The presence of mobile lipids has been detected by proton
magnetic resonance spectroscopy (
1H MRS) in animal and human
tumours: in cultured cells (Mountford and Wright, 1988; Le Moyec
et al, 1992), in biopsies (Lean et al, 1993; Kuesel et al, 1994a), and
in vivo (Ott et al, 1993; Negendank et al, 1996). The location of
these lipids has been widely discussed during the past years. The
lipid signal was first ascribed to neutral lipids, mainly triglycerides,
arranged in microdomains (25–28nm in diameter) embedded
within the phospholipid bilayer (Mountford and Wright, 1988). In
1993, Callies et al (1993) demonstrated a correlation between the
appearance of mobile lipids in proton magnetic resonance (MR)
spectra of myeloma cells, and the formation of cytoplasmic
droplets (1mm in diameter). A relation between the amount of
mobile lipids and the percentage of necrosis was also evidenced in
proton spectra of human brain tumour biopsies (Kuesel et al,
1994b). All these results encouraged Re ´my et al (1997) to make a
new estimate of the size of the compartment in which mobile lipids
were confined. Using in vivo diffusion measurements, they
hypothesised a link between mobile lipids detected by
1H MRS,
and the presence of necrosis and lipid droplets in a model of C6 rat
glioma. In addition, transmission electron microscopy of tumour
fragments showed increased numbers of lipid droplets with
increasing sizes from the periphery of the necrosis towards the
centre of the tumour (Re ´my et al, 1997). These results were
confirmed and extended by Lahrech et al (2001). By measuring the
mean displacement of mobile lipids in C6 rat brain glioma at
different diffusion times, a characteristic diameter of 4.7mm was
determined for the compartment that contains these lipids
(Lahrech et al, 2001). Consistent with this, we recently confirmed
that
1H MRS-visible mobile lipids in C6 rat glioma arise from lipid
droplets mainly located in the necrosis (Zoula et al, 2001).
Consequently, the detection of a high intensity of
1H MRS lipid
signal could be a signature of a very necrotic tissue and indicate
the tumour grade.
In several studies, a lower amount of smaller lipid droplets has
also been observed in the cytoplasm of viable tumour cells
surrounding the necrosis (Freitas et al, 1990; Re ´my et al, 1997;
Lahrech et al, 2001; Zoula et al, 2001). Lipid droplets and/or MRS
mobile lipids signal have been detected in various hypoxic and/or
ischaemic situations such as acute ischaemia in cat heart
(electronic microscopy) (Jodalen et al, 1985), human cerebral
infarction (
1H MRS) (Saunders et al, 1995; Hwang et al, 1996),
tumour hypoxic zones (fluorescence microscopy and electronic
microscopy) (Freitas, 1990; Freitas et al, 1996). It has been
proposed (Freitas et al, 1990, 1996; Re ´my et al, 1997) that these
lipid droplets could represent a temporary storage compartment
(final storage compartment if the tissue does not recover) of fatty
acids in the form of triglycerides. Under hypoxic or ischaemic
conditions, the fatty acids would not be degraded any more by
Received 15 July 2002; revised 28 December 2002; accepted 8 January
2003
*Correspondence: Dr C Re ´my, Laboratoire Mixte INSERM U438 ‘RMN
Bioclinique’ Centre Hospitalier Universitaire, Pavillon B BP 217 38043
Grenoble Cedex 09, France; E-mail: chantal.remy@ujf-grenoble.fr
British Journal of Cancer (2003) 88, 1439–1444
& 2003 Cancer Research UK All rights reserved 0007– 0920/03 $25.00
www.bjcancer.com
E
x
p
e
r
i
m
e
n
t
a
l
T
h
e
r
a
p
e
u
t
i
c
sb-oxidation. The harmful effects of the increase in the cell
concentration of free fatty acids would be avoided by sequestering
them in the form of triglycerides in lipid droplets. Thus, the
accumulation of lipid droplets in viable tumoral cells located at
the periphery of necrosis would result from a stress induced by
the hypoxic state of these cells (Freitas et al, 1990, 1996; Kuesel
et al, 1994b). This lipid accumulation would accelerate with the
necrotic process (Kuesel et al, 1994b).
Tumour hypoxia has long been considered as a limiting factor
in association with poorer outcome after radiotherapy, chemo-
therapy and surgery (Durand and Raleigh, 1998; Raleigh et al,
1999). Almost all macroscopic transplanted tumours in rodents
contain viable hypoxic cells, which are a major cause of
radioresistance (Rockwell and Moulder, 1990; Morioka et al,
1992). Since past years, many studies have shown a sustained
interest in development of techniques for detecting hypoxia.
However, methods for identifying hypoxic viable tumour
cells in cancer patients remain limited (Durand and Raleigh,
1998). Thus, the incidence of hypoxia in human brain
tumours before and during radiotherapy is poorly understood
(Parliament et al, 1997). The existence of a technique, which
would allow a simple detection of hypoxic cells, would constitute
an undeniable advantage for the diagnosis, the prognosis,
the orientation and therapeutic follow-up of cancers. In this
study, we hypothesised that the presence of lipid droplets is
related to the occurrence of hypoxia near necrosis. To validate
this hypothesis, hypoxia marker binding was analysed in relation
to necrosis and lipid droplets in histological sections of C6 rat
gliomas. The use of lipid droplets as an indicator of necrosis
and/or hypoxia was thus evaluated.
MATERIALS AND METHODS
Experimental model of intracerebral glioma
Intracerebral tumours were induced by C6 cells, a cell line derived
from a chemically induced malignant rat glioma (Benda et al,
1971). A measure of 5ml of cell suspension, 10
5 cells, (prepared in
Dulbecco’s modified Eagle’s medium (DMEM) supplemented with
2% glutamine and 1% antibiotics) were stereotactically injected
3mm below the dura in the right caudate nucleus of six female
Wistar rats (160–180g) (Workman et al, 1998).
All operative procedures and animal care strictly conformed to
the French Government guidelines (decree no. 87-848 of 19
October 1987, licenses 006722 and A38071).
Immunohistochemistry and section analysis
A multiple fluorescence staining technique combined with a digital
image analysis was used to study quantitatively tumour vascular-
ity, perfusion, hypoxia and lipids in the same section (Rijken et al,
2000). Pimonidazole (1-[(2-hydroxy-3-piperidinyl) propyl]-2-
nitroimidazole hydrochloride) was used as a hypoxia marker
(Kennedy et al, 1997; Durand and Raleigh, 1998; Varia et al, 1998;
Raleigh et al, 1999), Hoechst 33342 was utilised for the detection of
perfused vasculature, and anticollagen type IV was used as an
anatomical marker of all vessels.
Experiments were carried out by the end of the tumour
development (22–25 days after tumour cell implantation). Rats
were injected with a 0.25ml solution of pimonidazole in
phosphate-buffered saline (PBS, pH 7.4) (80mgkg
 1 of body
weight; Natural Pharmaceuticals International Inc., Research
Triangle Park, NC, USA) and a 0.25ml solution of Hoechst
33342 in PBS (24mgkg
 1 of body weight; Sigma-Aldrich, Saint-
Quentin-Fallavier, France). These markers were administrated
intravenously via one of the tail veins, 60 and 1min before killing,
respectively.
Brains were quickly removed (less than 3min after the rat
death), frozen in liquid nitrogen then stored at  801C to prevent
the Hoechst from diffusing further into the tissue.
For each rat, two adjacent transversal sections (5mm thick) were
cut at mid-tumour (where the tumour was the largest). To analyse
the morphology of the tumour, the first section was stained with
haematoxylin/eosin (HE). The second section was analysed on the
digital image analysis system. This section was first scanned to
obtain a composite image with perfused areas (Hoechst binding),
followed by fixation in 10% buffered formaldehyde. Next, lipid
droplet staining was performed with a specific lipid dye, Red Oil
(Fowler and Greenspan, 1985) (Fluka Chemie AG, Buchs, Switzer-
land). Then, the section was incubated for 90min at 41C with
primary antibodies: 1:100 dilution of a goat polyclonal antibody
against collagen type IV (Southern Biotechnology Associates,
Birmingham, AL, USA), and 1:200 dilution of a rabbit polyclonal
antibody against pimonidazole both in PBS with 0.5% BSA-c
(BSA-c; Aurion, Wageningen, The Netherlands). This step was
followed by incubation with secondary fluorescent antibodies for
2h: 1:100 dilution of the Alexa Fluor
s 546 IgG (HþL) donkey
anti-goat (Molecular Probes, Eugene, OR, USA) and 1:100 of the
Fluorescein FITC-conjugated IgG (HþL) donkey anti-rabbit
(Jackson ImmunoResearch Laboratories, West Grove, PA, USA)
both in PBS with 0.5% BSA-c.
The sections stained with HE were evaluated by light micro-
scopy using a Nikon Eclipse E600 microscope equipped with an
Olympus DP 50 video camera and an image analysis system
(analySIS) developed by Olympus (Soft Imaging System, Mu ¨nster,
Germany). Tumour and necrosis areas were measured and the data
were classed according to the necrotic fraction, R, defined as the
necrotic area divided by the total tumour area. Tumour perfusion,
vascularity and oxygenation were analysed using the system
described by Rijken et al (1995, 2000). Briefly, the fluorescence
signals were recorded by a high-resolution intensified solid-state
black and white video camera. The video signal was digitised to
images with 256 grey levels, and the digital imaging application
TCL-Image (TNO, Delft, the Netherlands) was used for acquiring
and further processing the images. Before scanning a series of
particular fluorophore, the automated scanning stage was initi-
alised and calibrated and a threshold grey value to segment the
objects from the background was determined and recorded.
The perfused areas (Hoechst) were visualised on the fluores-
cence microscope using a filter with excitation at 365nm and
emission at 420nm. During each scan, which consisted of a
selectable meander pattern from 4 4t o1 2 12 fields, according
to the size of the tumour, the previously recorded threshold value
was used to isolate the perfused area from the background in a
black and white image. After each scan, a composite image of the
perfused areas was reconstructed from the recorded and processed
black and white images of each field. After immunohistochemical
staining for hypoxia and vasculature, sections were scanned on the
image analysis system. A filter combination of 450–490nm
excitation and 520nm emission was used for hypoxia and a filter
with excitation at 510–560nm and emission at 590nm was used to
analyse the vasculature. The sequentially recorded composite
images of the tumour sections with detected perfused areas,
hypoxia and total tumour vascular bed, respectively, were
displayed using pseudocolours for each structure. Lipid droplets
were visualised by light microscopy, and the amount of the
droplets was qualitatively estimated: low (þ), high (þþ).
A multiparameter analysis of vascularity, perfusion and hypoxia
in tumour sections was finally performed. Measured parameters
were: the perfused fraction (PF, area of perfused vascular
structures divided by the total vascular area), the relative vascular
area (RVA, total vascular area divided by the total tumour area),
the hypoxic fraction (HF, total hypoxic area divided by the viable
tumour area). The number of vascular structures per mm
2 (VD) as
well as the perfused vascular density (VDp) were also calculated.
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sFor each tumour section, the composite images with vascular
structures, perfused areas and hypoxic regions were combined,
resulting in a new image with the overlapping structures
representing the three parameters. In randomly selected regions
of interest (approximately 10 ROIs per tumours), each including at
least one perfused vessel near a hypoxic region adjoining tissue
necrosis, distances from perfused vessels to necrotic areas,
crossing hypoxic regions, were measured in manually drawn
rectangles. In addition, pimonidazole-binding intensity as a
function of distances to perfused vessels was measured using a
12-bit image analysis system (Rijken et al, 2000).
RESULTS
Occurrence of necrosis and lipid droplets
Table 1 summarises tumour characteristics after HE and lipid
droplets staining. All rats developed tumours characterised by the
presence of necrotic tissue. The three largest tumours (rats 1, 2 and
4) exhibited extensive areas of necrosis (respectively, 30.9, 36.9 and
42.7% of total tumour area) surrounded by cells arranged into
pseudopalisade (Figure 1A). A high number of lipid droplets were
observed mainly in necrosis, and some smaller droplets were
located in ‘pseudopalisadic’ cells (Figure 1B). Two other tumours
(rats 3 and 5) showed focal necrotic regions (1.2 and 5.8% of total
tumour area) that contained low amounts of lipid droplets. The
necrotic area of one of the two rats (rat 5) was surrounded by
viable cells arranged into pseudopalisade. Some droplets were
visible in this area. The last tumour (rat 6) was characterised by a
moderate necrotic area (18.5% of total tumour surface) and a high
number of lipid droplets located in the tissue necrosis. Even if no
precise quantification was performed, the number and the size of
lipid droplets seemed to increase through the pseudopalisade
towards the necrotic areas of all tumours.
Lipid droplets in relation to perfusion, vasculature
and hypoxia
As is illustrated by the composite digital image in Figure 2, the
vasculature of the tumours was not homogenously distributed.
This vasculature (red fluorescence) consisted of a number of large
vessels dispersed within the tumour. The necrotic core of the
tumour was nearly devoid of vessels. The mean value of the RVA
was approximately 0.02170.019 (Table 2). Hoechst binding (blue
fluorescence) was restricted to a small area around the perfused
vessels (Figure 2). The multiparameter analysis also showed that
more than half of the vessels were perfused: PF represents
approximately 64% of the total vascular area (Table 2). In some
tumours nonperfused vessels were observed inside necrosis.
Hypoxia (green fluorescence) was mainly detected adjacent to
necrosis, as shown in Figure 2. However, pimonidazole-binding
cells did not uniformly surround the necrosis. In addition, some
hypoxic cells were sometimes found within the necrotic tissue.
Owing to technical problems, the hypoxic fraction was only
measured on four rats out of six. The mean hypoxic fraction was
0.02370.010 (Table 2). No inverse correlation was found between
PF and HF. On the other hand, the density of the perfused vessels
seemed to correlate with the hypoxic fraction (Table 2).
Measurements performed on about 40 ROIs selected randomly
inside the tumours (Figure 3A) showed an average value of
114750mm for the minimal distance from a perfused vessel to the
nearest hypoxic cells. At increasing distance from vessels,
pimonidazole binding rapidly increased from background level
to a maximum and decreased to background level into the necrotic
tissue. An example of this hypoxia gradient is shown in Figure 3B.
The maximal intensity of the bound hypoxic marker varied from
tumour to tumour and among the different ROIs of a single
tumour. For the first rat, for example, the values obtained in 13
ROIs ranged from 402 to 2650 grey values.
Small lipid droplets were observed in hypoxic regions, but only
in hypoxic cells adjacent to necrosis (Figure 3A). The average
minimal distance between a perfused vessel and the first lipid
droplets was approximately 181772mm.
Previous studies were performed on 14 other rats (respectively,
4, 5 and 5 rats for each series). The results are not shown here,
Table 1 Tumour characterisation after HE and lipid droplets staining
Macroscopic analysis HE Lipid staining
Rats Tumour area (mm
2) Necrosis (R %) Lipid droplets
1 42.8 30.9 ++
2 41.2 36.9 ++
3 16.9 1.2 +
4 33.2 42.2 ++
5 23.5 5.8 +
6 7.3 18.5 ++
HE¼haematoxylin and eosin staining. R represents the necrotic fraction defined as
the necrotic area divided by the total tumour area. Lipid droplets: +¼low;
++¼high.
Figure 1 Haematoxylin and eosin (A) and Red Oil (B) staining of a rat
brain section observed 25 days postimplantation. The tumour exhibited an
extensive area of necrosis limited by cells arranged into pseudopalisade (A).
Lipid droplets were observed mainly in the necrotic zone and also in the
cytoplasm of viable tumoral cells surrounding necrosis (B). Enlargements of
B show the presence of small lipid droplets (indicated by arrows) in viable
cells at the periphery of necrosis (1) and large lipid droplets within the
necrosis (2). T¼tumour, NE¼necrosis, PP¼cells arranged into pseudo-
palisade, NT¼nontumoral tissue, LD¼lipid droplets.
Lipid droplets in tumour hypoxia
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ssince the previous immunohistological protocol did not include
the staining for functional and permeable vessels. However, similar
results compared to those presented here were observed concern-
ing hypoxia binding and the presence of small lipid droplets in the
hypoxic cells adjacent to necrosis.
DISCUSSION
It has been suggested that the presence of lipid droplets in viable
cells surrounding necrosis could be related to hypoxia (Freitas et al,
1990; Kuesel et al, 1994b). The aim of this study was to determine
whether these cells were indeed hypoxic and if lipid droplets could
be considered as a surrogate marker of hypoxia.
Localisation of hypoxic regions
Despite the interest in the hypoxic cell detection, methods for
reliably and conveniently identifying and quantifying hypoxic
viable tumour cells in cancer patients have remained limited
(Durand and Raleigh, 1998). Presently, the use of molecules
derived from 2-nitroimidazole, which are selectively reduced in the
presence of a low oxygen concentration, has been adapted to
nonradioactive immunohistochemical assays for the detection of
hypoxic cells. Pimonidazole has now been applied to human
tumours (Kennedy et al, 1997; Varia et al, 1998; Raleigh et al,
1999). This marker is sensitive to the oxygen variations: it is
metabolized at pO2 lower than 10mmHg, only in viable cells
(Durand and Raleigh, 1998; Evans et al, 2000). As no pimonidazole
binding occurs in the necrotic areas, it is possible to distinguish
these anoxic zones from the hypoxic areas.
Under normal conditions of oxygenation, hypoxia could be
related to tumour perfusion and vascularity (Koukourakis et al,
2000). Hypoxic conditions can be expected either around a less-
perfused blood vessel (acute hypoxia) or beyond O2-diffusion
distance from well-perfused vessels (chronic hypoxia). In the
present study, no inverse correlation was found between hypoxic
fraction and perfused fraction (Table 2). This result could be
influenced by the presence of areas of necrosis in the tumours.
Actually, as illustrated in Figure 2, C6 rat glioma is characterised
by a high heterogeneity of vasculature density in the different parts
of the same tumour: the necrotic centre of the tumour is
completely anoxic and almost devoid of vessels. The intratumour
vascular density is higher in peripheral areas than in the central
necrotic core of the tumours. Such a vessel distribution was also
described in an experimental mouse mammary carcinoma
(Thompson et al, 1987) and in human carcinomas (lung, breast,
colon and endometria) (Koukourakis et al, 2000). In addition, the
most pronounced vascular density affected the adjacent connective
NE
PP
1 mm
Figure 2 Pseudocoloured composite binary image obtained after
sequential scanning for total vascularisation (red), perfusion (blue) and
hypoxia (green), respectively, in a rat brain section. NE¼necrosis,
PP¼cells arranged into pseudopalisade.
Table 2 Quantification of perfusion, vasculature and hypoxia in rat
gliomas
Rats PF RVA VD VDp HF
1 0.71 0.011 19.2 14.0 0.029
2 0.28 0.007 13.8 4.2 F
3 0.81 0.024 29.0 20.8 0.023
4 0.60 0.014 20.2 9.3 0.008
5 0.78 0.015 26.5 19.0 0.032
6 0.65 0.055 53.7 30.8 F
Mean7s.d. 0.6470.19 0.02170.017 27.0714.0 16.379.4 0.02370.010
PF¼perfused fraction, RVA¼relative vascular area, VD¼vascular density including
all vessels, VDp¼vascular density including only perfused vessels, HF¼hypoxic
fraction. s.d.¼standard deviation.
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Figure 3 Pseudocoloured 12-bit grey-level image obtained in a selected
ROI including at least one perfused vessel near a hypoxic region adjoining
tissue necrosis. The black rectangle represents the area in which distances
were measured (A). The intensity of pimonidazole binding increases from a
perfused vessel to the edge of necrosis (A). This hypoxic gradient is
illustrated in (B); the green arrow shows the mean distance where hypoxia
(pO2o10mmHg) starts to occur: approximately 114mm. The pink arrow
shows the mean distance where lipid droplets start to occur: approximately
181mm. Thus, small lipid droplets are present in hypoxic regions, but only in
cells adjacent to necrosis (A). Ves¼perfused vessel, Hyp¼hypoxic region,
LD¼lipid droplets, NE¼necrosis.
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stissue. Consistent with this, our results support the general belief
that some tumour periphery in proximity of normal structures are
better oxygenated than central tumour areas that suffer from
hypoxia and undergo necrosis (Thompson et al, 1987). This
implies a diffusion-limited hypoxia, determined by the spatial
distribution of the perfused vessels. The values obtained for the
relative vascular area in each tumour (Table 2) are very low
compared to the results described in the literature (0.052–0.2), for
human glioma xenografts (Rijken et al, 1995, 2000). This result
could also be explained by the variation in the angiogenic profile of
the different sorts of tumours analysed (Rijken et al, 1995;
Koukourakis et al, 2000).
In C6 rat glioma, chronic hypoxia occurs at a minimal distance
of 114mm from a perfused vessel, a value in the range of those
already described in the literature (100–200mm) (Vaupel et al,
1989; Rijken et al, 2000). From this distance, pimonidazole binding
was found to increase from background level to a maximum at the
far end of a hypoxic region (Figure 3A), resulting in a hypoxia
gradient. Beyond the critical distance of 114mm, cells might
become more and more hypoxic, some of them might die from the
lack of oxygen and nutrients, leading to regions of necrosis
completely devoid of oxygen (anoxic regions). This decreasing
gradient in oxygen concentration from vessels has also been
reported in in vitro studies (spheroids) (Franko et al, 1992), and in
vivo studies (tumour tissue) (Franko et al, 1987; Kennedy et al,
1997; Parliament et al, 1997). Although in C6 gliomas elevated
pimonidazole binding is mainly found in some areas adjacent to
necrosis (Figure 2), it should be noticed that hypoxia does not
form a continuous rim around the necrosis. This contrasts with the
classical finding of heavily labelled cells uniformly surrounding
necrosis in murine tumours (Chapman et al, 1983).
In their report, Parliament et al (1997) also described
unexpected anomalous patterns of nitroimidazole binding adjacent
to necrosis in human glioma xenografts. The finding of some
regions around the necrotic tissue that are not heavily labelled
raises the possibility that necrosis can occur despite an absence of
significant hypoxia (Parliament et al, 1997). This result could be
explained if we considered that the rate of oxygen consumption
might be different according to the regions observed. Hypoxic
regions around necrosis should represent ‘oxygen conformer cell’,
whose rate of oxygen consumption varies with the availability of
oxygen (Parliament et al, 1997). In some microregions, necrosis
may occur despite an absence of notable hypoxia through the
diminution of substrates other than oxygen, such as glucose
(aerobic and/or anaerobic glycolysis) (Parliament et al, 1997). The
variation in maximal pimonidazole-binding intensity between
tumours and within ROIs is another indication for the existence of
‘oxygen conformer cell’. This variation could also be explained by
a variation in capability of tumour cells to bind pimonidazole, if it
is considered that this fixation depends on the concentration of
fixing protein. Thus, our results show that the degree of hypoxia is
not always equal in different tumours observed at the same stage of
development, as well as in various zones of a tumour.
Hypoxia and lipid droplets
Our results revealed the presence of lipid droplets in the cytoplasm
of tumoral cells in a few layers of cells surrounding necrosis. Visual
evaluation showed an increase in the number of these droplets
from the periphery of the necrosis towards the centre of the
tumours. The larger droplets were located in the necrotic core of
the tumours and the smaller droplets were present in the hypoxic
cells surrounding necrosis. However, these droplets were not
observed in all hypoxic cells, rather in the most hypoxic cells
adjacent to necrosis. This could be explained by the existence of a
progressive degeneration of mitochondria as the hypoxic gradient
increased. In 1990, Freitas et al already showed that lipid droplets
were associated with degenerating mitochondria in Ehrlich
carcinoma (Freitas, 1990; Freitas et al, 1990). At the distance from
a perfused vessel where hypoxia (pO2o10mmHg) starts to occur
(approximately 114mm according to our results) mitochondrial
structures might still allow the activity of the respiratory chain,
avoiding the production of lipid droplets. Beyond this critical
point, mitochondria might degenerate as the availability of oxygen
decreased, leading to a complete disintegration at pO2 below a
certain value corresponding to an approximate distance of 181mm
from a perfused vessel, according to our results. Hypoxic cells
might thus produce lipid droplets as a temporary (or end point, if
the tissue does not recover) storage compartment for lipids
(Freitas et al, 1990; Re ´my et al, 1997). Hence, lipid droplets
occurrence seemed to depend on oxygen concentration below a
relatively low pO2 value. This hypothesis is strengthened by recent
results of Scarfo et al (2001). By studying systemic and pulmonary
endothelial cells exposed to acute and/or chronic hypoxia, the
authors observed an induction of lipid bodies which was O2-
concentration dependent. Exposure to 0% O2 caused obvious
induction of lipid bodies in the cytoplasm of the cells. Exposure to
less severe hypoxia (10% or 3% O2) also induced formation of lipid
bodies observable with Red Oil staining. However, in this latter
case, the number of lipid bodies appeared fewer than that observed
at 0% O2 (Scarfo et al, 2001). This could explain the accumulation
of lipid droplets in the anoxic necrotic center of C6 tumours, and
the presence of a smaller number of droplets inside the hypoxic
cells surrounding this necrosis. Therefore, the presence of lipid
droplets in cells could be considered as an indicator of a severe,
prenecrotic hypoxia, and could be useful for the stratification of
tumours in nonhypoxic, hypoxic and severe hypoxic regions to get
a targeted treatment for each zone.
The ‘hypoxic’ lipid droplets certainly contribute to the signal of
mobile lipids detected by in vivo
1H MRS. But, these droplets often
represent a smaller percentage compared to large droplets
localised in the necrotic tissue. Consequently, the occurrence of
MRS lipid signal could be considered as an indicator of necrosis
and/or severe hypoxia. Now, the problem is to distinguish between
the signal arising from ‘necrotic’ lipid droplets and the one that
comes from ‘hypoxic’ lipid droplets. If this distinction was feasible,
it would constitute a noninvasive and nonradioactive method for
detecting the presence of necrosis and revealing the existence of
hypoxic zones within a tumour.
CONCLUSION
The present study shows that at late stages of C6 rat brain glioma
development, hypoxia (pO2o10mmHg) occurs at a distance of
about 100mm from a perfused vessel, and is mainly detected
around the necrotic area. The hypoxia marker binding intensity is
considerably variable between tumours and within the different
regions of the same tumour. This information on the degree of
hypoxia could be useful in tumour treatment. Indeed, a variable
dose of irradiation could be applied according to whether the
tumour is more or less hypoxic.
Small-sized lipid droplets are not detected in all hypoxic cells
but only in the highly hypoxic, prenecrotic ones. As a conse-
quence, lipid droplets could only be associated with a severe,
prenecrotic hypoxia and cannot be considered as a surrogate
marker of a moderate hypoxia.
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